Dr. Bratman's laboratory is developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer. The team is also interested in leveraging tumor genomics and radiomics data to improve upon curative treatment approaches for head and neck cancers.
See more on Dr. Bratman's lab here.